Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Genmab
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Escalating Regulatory Scrutiny And Patent Risks Will Constrain Margins
Key Takeaways Reliance on a few key oncology products and limited pipeline diversification exposes the company to significant competitive, regulatory, and exclusivity risks. Mounting pricing pressures and escalating research costs threaten profitability, making sustainable earnings growth dependent on successful new product launches.
View narrative
DKK 1.00k
FV
57.4% overvalued
intrinsic discount
7.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
1 day ago
author updated this narrative
SCHOTT Pharma KGaA
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Aging Population And Biologics Growth Will Fuel Advanced Packaging
Key Takeaways High-value solutions, sustainable packaging, and integration into new therapies position SCHOTT Pharma for accelerated profit and margin growth above market expectations. Rapid capacity expansion and emerging market entry are set to drive faster supply growth, recurring revenues, and outperformance versus industry peers.
View narrative
€36.00
FV
34.7% undervalued
intrinsic discount
12.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Nippon Yusen Kabushiki Kaisha
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Rising Decarbonization Costs And Digital Disruption Will Crush Profits
Key Takeaways Costly regulatory and environmental demands, along with rising competition, threaten margins and place long-term pressure on net earnings and market share. Rapid tech disruption, global overcapacity, and geopolitical risks undermine pricing power and revenue growth, diminishing earnings stability and predictability.
View narrative
JP¥3.82k
FV
38.0% overvalued
intrinsic discount
-5.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Bunzl
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Rising Regulatory, Labor And Logistics Costs Will Erode Valuation
Key Takeaways Heightened regulatory, supply chain, and labor pressures threaten Bunzl's core packaging business, with rising costs and regulatory shifts squeezing profits and revenue growth. Digital transformation and industry consolidation are undermining Bunzl's intermediary role, increasing competitive risks and requiring costly investment to maintain relevance and margins.
View narrative
UK£19.00
FV
24.6% overvalued
intrinsic discount
0.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Samvardhana Motherson International
AN
AnalystLowTarget
Consensus Narrative from 23 Analysts
EV Shift Will Squeeze Margins Though Emerging Markets Offer Respite
Key Takeaways Dependence on traditional components and aggressive acquisitions exposes the company to integration, margin, and long-term demand risks amid shifts toward electric vehicles and industry consolidation. Geopolitical disruptions, rising automation, and heavy capital spending heighten cost pressures and threaten profitability, while undermining market share in developed regions.
View narrative
₹82.83
FV
18.2% overvalued
intrinsic discount
4.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
Indorama Ventures
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Urbanization And Recycling Will Expand Global PET Packaging Markets
Key Takeaways Ongoing asset rationalization, AI-driven transformation, and vertical integration are set to significantly boost efficiency, margins, and innovation beyond current market expectations. Leadership in sustainable packaging and strategic global positioning enables premium pricing, sustained volume growth, and resilience amidst shifting market and regulatory dynamics.
View narrative
฿29.00
FV
19.0% undervalued
intrinsic discount
11.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Technip Energies
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Decarbonization And Hydrogen Will Drive Global Megaproject Expansion
Key Takeaways Scaling of proprietary technologies and consulting, along with modularization, is driving margin outperformance and positions the company for sustained profit growth and revenue scalability. Accelerating decarbonization-related orders and strategic alliances are expanding market reach, ensuring robust backlog and positioning Technip Energies as a global leader in energy transition solutions.
View narrative
€50.00
FV
17.8% undervalued
intrinsic discount
11.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Repsol
AN
AnalystLowTarget
Consensus Narrative from 24 Analysts
Fossil Fuel Revenues Will Diminish As European Policies Tighten
Key Takeaways Structural headwinds from decarbonization, oversupply, and ESG pressures threaten core profitability and increase the risk of stranded assets and write-downs. The slow pace of renewables expansion limits competitive positioning and future earnings growth, while rising capital costs constrain shareholder returns.
View narrative
€11.00
FV
25.9% overvalued
intrinsic discount
-5.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
Xero
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Cyber Threats And Regulation Will Erode Value But Encourage Recovery
Key Takeaways Regulatory challenges, cybersecurity risks, and rapid AI advancements threaten Xero's profitability, requiring increased investment in compliance, security, and innovation to stay competitive. Market saturation and intensifying competition are likely to slow subscriber and revenue growth, while rising costs strain operating margins and long-term earnings potential.
View narrative
AU$137.41
FV
23.0% overvalued
intrinsic discount
12.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies